Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Vitamin D supplementation in chronic spinal cord injury (VitD-SCI): study protocol for a randomised controlled trial

Vitamin D supplementation in chronic spinal cord injury (VitD-SCI): study protocol for a randomised controlled trial

BMJ Open, 2021 · DOI: 10.1136/bmjopen-2021-053951 · Published: November 29, 2021

Spinal Cord InjuryNutrition & DieteticsRehabilitation

Simple Explanation

Vitamin D insufficiency is common in individuals with spinal cord injury (SCI) and can negatively impact musculoskeletal, immune, and respiratory systems. This study investigates the effect of vitamin D supplementation over 12 months on vitamin D status and secondary health parameters in individuals with chronic SCI. Participants will be randomly assigned to receive either a monthly dosage of 24 000 IU or 48 000 IU vitamin D, or a placebo.

Study Duration
12 months
Participants
45 individuals with chronic SCI
Evidence Level
Level 1, Randomized, placebo-controlled, double-blinded superiority trial

Key Findings

  • 1
    The primary outcome is the change in vitamin D status after 12 months of supplementation.
  • 2
    Secondary outcomes include bone mineral density, handgrip strength, fatigue, mood, pain, and pressure injuries.
  • 3
    The study will assess the safety and tolerance of vitamin D supplementation in individuals with chronic SCI.

Research Summary

This study protocol presents a randomised, placebo-controlled trial (VitD-SCI) to investigate the impact of 12 months of vitamin D supplementation on vitamin D status and secondary parameters in individuals with chronic spinal cord injury (SCI). The trial will involve 45 participants with chronic SCI who will be randomly assigned to receive either a monthly dosage of 24 000 IU or 48 000 IU of vitamin D, or a placebo. Measurements will be taken every 3 months to assess vitamin D status, bone mineral density, handgrip strength, fatigue, mood, pain, and pressure injuries, while also evaluating the safety and tolerance of vitamin D supplementation.

Practical Implications

Inform Clinical Recommendations

The study aims to provide insights for optimizing individual vitamin D supplementation strategies in chronic SCI.

Standardized Management

If a positive relation between vitamin D status and secondary outcomes is established, this could lead to standardized clinical recommendations.

Community-based Policy

The evidence acquired during this study will effectively inform community-based policy regarding vitamin D supplementation in chronic SCI.

Study Limitations

  • 1
    Adherence to the protocol cannot be objectively assessed due to the home-based setting.
  • 2
    Dietary vitamin D intake will not be assessed, precluding scaling of vitamin D efficacy to variations in nutrition.
  • 3
    Not all relevant clinical outcomes, such as respiratory and immune function, can be assessed due to feasibility.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury